Get started
Author

Ming Yuan

ORCID: 0009-0001-4147-972X
Observed ORCID: 0009-0001-4147-972X
OpenAlex ID: A5115959280
Granular cell astrocytoma: an aggressive IDH ‐wildtype diffuse glioma with molecular genetic features of primary glioblastoma
2018 · M. Adelita Vizcaino, Doreen N. Palsgrove, et al. · Brain Pathology · 15
Abstract 3106: Integrated in vitro and machine learning approaches for targeted drug screening in gliomas with concurrent NF1 and ATRX loss
2024 · Swati Dubey, Somesh Mohapatra, et al. · Cancer Research · 1
RECQL4 alterations in gliomas and nerve sheath tumors: Expression patterns and therapeutic implications
2025 · Sarra Belakhoua, Gianluca Lopez, et al. · Journal of Neuropathology & Experimental Neurology
Nfb-01. Functional Characterization of Atrx Loss in Nf1-associated Glioma and Mpnst
2020 · Ming Yuan, Karlyne Reilly, et al. · Neuro-Oncology
PDF
PDTM-18. COMBINED SUPPRESSION OF THE mTOR AND MAPK PATHWAYS INHIBITS GROWTH, DECREASES VASCULARITY AND INDUCES APOPTOSIS OR SENESCENCE IN PEDIATRIC LOW GRADE GLIOMA
2019 · Antje Arnold, Lauren Harris, et al. · Neuro-Oncology
PDF
Pdct-02. Combined Inhibition of Mtorc1/c2 and Mek Pathway Is Synergistic in Preclinical Testing of Pediatric Low-grade Glioma Including a Novel Patient-derived Nf1 Pilocytic Astrocytoma Cell Line
2018 · Antje Arnold, Ming Yuan, et al. · Neuro-Oncology
PDF
Abstract B14: Establishment and characterization of in vitro models of alternative lengthening of telomeres (ALT) in pediatric high-grade glioma
2018 · Jacqueline A. Brosnan-Cashman, Mindy K. Graham, et al. · Cancer Research
LGG-52. DUAL INHIBITION OF mTORC1/C2 AND MEK PATHWAY IS SYNERGISTIC IN MULTIPLE HUMAN MODELS OF PEDIATRIC LOW-GRADE GLIOMA INCLUDING A NOVEL PATIENT-DERIVED NF1 PILOCYTIC ASTROCYTOMA CELL LINE
2018 · Antje Arnold, Ming Yuan, et al. · Neuro-Oncology
PDF
Abstract 3465: Context-dependent effects of ATRX loss on telomere biology in glioma cells
2017 · Jacqueline A. Brosnan-Cashman, Ming Yuan, et al. · Cancer Research
Abstract 3466: ALT-positive pediatric high grade glioma cells display chemosensitivity to ATR pathway inhibition
2017 · Jacqueline A. Brosnan-Cashman, Anthony J. Rizzo, et al. · Cancer Research
Works count: 10
Citation count: 16
H-index: 1
I10-index: 1
Year
Topic
Type